Cover Image
市場調查報告書

離子通道調節劑的全球市場

Ion Channel Modulators

出版商 Global Industry Analysts, Inc. 商品編碼 269629
出版日期 內容資訊 英文 161 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
離子通道調節劑的全球市場 Ion Channel Modulators
出版日期: 2015年04月01日 內容資訊: 英文 161 Pages
簡介

本報告提供全球離子通道調節劑市場相關調查,提供您2014∼2020年的市場趨勢預測,產品概要,各地區趨勢,及加入此市場的主要企業簡介等彙整資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 產業概要
    • 離子通道調節劑:倒退的市場
    • 現在及未來分析
    • 專利失效對離子通道調節劑的影響
    • 現在市場上可取得的離子通道調節劑藥物
    • 各作用機制離子通道調節劑藥物
    • 競爭模式
  • 治療傾向別離子通道調節劑
    • 心血管疾病/高血壓
    • 以離子通道為標的抗高血壓劑:2014年
    • 心律不整治療上的離子通道調節劑
    • 痙攣上的離子通道調製
    • 疼痛管理上的離子通道調製
    • 腫瘤學上的離子通道調製
    • 抗糖尿病藥物上的離子通道調製
    • 制吐劑上的離子通道調製
    • 確認離子通道調節劑可廣泛用於沒發現的局部疾病
    • 其他治療領域上的離子通道調製
  • 市場趨勢
    • 高齡化:促使市場持續成長
    • APC的離子通道篩檢
    • 離子通道服務的委外日益熱門
    • 限制與課題
    • 離子通道:困難的藥物對象
    • 學名藥的威脅
  • 產品概要
  • 近幾年的產業活動
  • 主要企業
    • AstraZeneca
    • Bayer HealthCare
    • CalciMedica, Inc.
    • Convergence Pharmaceuticals Limited
    • Evotec AG
    • Forest Laboratories, LLC
    • GlaxoSmithKline Plc.
    • Johnson & Johnson
    • Lundbeck
    • Novartis AG
    • Parion Sciences, Inc.
    • Pfizer, Inc.
    • Neusentis, Inc.
    • Sanofi S.A.
    • Targacept, Inc.
    • Xention Limited
  • 全球市場預測

第3章 各國市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
  • 亞太地區各國
    • 中國
    • 印度
  • 南美各國
    • 巴西
  • 其他各國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6940

This report analyzes the worldwide markets for Ion Channel Modulators in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2018. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 47 companies including many key and niche players such as -

AstraZeneca
Bayer HealthCare
CalciMedica, Inc.
Convergence Pharmaceuticals Limited
Evotec AG

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Ion Channel Modulators - A Receding Market
  • Current and Future Analysis
  • Impending Patent Expiries of Select Ion Channel Modulators
  • Currently Available Ion Channel Modulating Drugs in the Market
  • Select Ion Channel Modulator Drugs by Mode of Action
  • Competitive Scenario
    • Table 1: Global Ion Channel Modulators Market by Top Ten Drugs (2013): Percentage Share Breakdown of Revenues (includes corresponding Graph/Chart)

2. ION CHANNEL MODULATORS BY THERAPEUTIC INDICATION

  • Cardiovascular Diseases/ Hypertension
  • Select Major Anti-Hypertensive Drugs Targeting Ion Channels: 2014
    • Table 2: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart)
    • Table 3: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart)
    • Table 4: Fatalities in High Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD, Cancer, Injury, and Others (includes corresponding Graph/Chart)
    • Table 5: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
    • Table 6: Fatalities in Low Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart)
  • Ion Channel Modulation in Arrhythmia Treatment
    • Select Anti-Arrhythmic Drugs Targeting Ion Channels: 2014
  • Ion Channel Modulation in Convulsions
    • Select Anti-Convulsant Drugs Targeting Ion Channels: 2014
  • Ion Channel Modulation in Pain Management
    • Pain Management/Analgesic Drugs Targeting Ion Channels: 2014
  • Ion Channel Modulation in Oncology
  • Ion Channel Modulation of Antidiabetic Agents
  • Ion Channel Modulation of Antiemetics
  • Ion Channel Modulators Find Extensive Use in Neglected Tropical Diseases
  • Ion Channel Modulation in Other Therapeutic Areas
    • Select Ion Channel Modulators for Other Therapeutic Indications: 2014

3. MARKET DYNAMICS

  • Aging Population: Sustaining the Market
    • Table 7: Global Population Worldwide: Percentage Share Breakdown by Age Group for the year 2025 (includes corresponding Graph/Chart)
    • Table 8: Global Population of People Aged 65+ Years (In Million) for the Years 2012, 2020 & 2050 (includes corresponding Graph/Chart)
  • Ion Channel Screening Aided by APC
  • Increased Interest Witnessed in Outsourcing of Ion Channel Services
  • Limitations and Challenges
  • Ion Channels - Difficult Drug Targets
  • The Threat Posed by the Influx of Generic Drugs

4. PRODUCT OVERVIEW

  • Ion Channel Modulators: An Introduction
  • Biological Significance of Ion Channels
  • Ion Channel Modulators as an Option for Treating Diseases
  • Types of Ion Channels
  • Voltage-Gated Ion Channels
  • Extracellular Ligand-gated Ion Channels
  • Intracellular Ligand-gated Ion Channels

5. RECENT INDUSTRY ACTIVITY

  • Pfizer Wins Court Ruling to Block Generic Versions of Lyrica Upto 2018
  • Forest Labs Discontinues Namenda 5/10 mg Tablets, Launches Namenda XR
  • Forest Files Lawsuit against Namenda Generic Manufacturers
  • Cytocentrics Bioscience Selects Drug Safety Testing Center as its Distributor in Japanese Market
  • Zalicus Licenses Its Entire Sodium Channel Modulator Program to AnaBios Corporation
  • EPIRUS Merges with Zalicus
  • XENTION Collaborates with SERVIER for Kv1.5 Modulator Project
  • Aurora Biomed Inks Agreement with Specs and Alion Pharmaceuticals
  • Hydra and Zalicus Enter into Partnership
  • Hydra Biosciences and Cubist Pharmaceuticals to Commence Phase 1 Clinical Trial for TRPA1 Antagonist CB-625
  • Vertex Pharmaceuticals Receives USFDA Approval for KALYDECO™

6. FOCUS ON SELECT GLOBAL PLAYERS

  • AstraZeneca (UK)
  • Bayer HealthCare (Germany)
  • CalciMedica, Inc. (US)
  • Convergence Pharmaceuticals Limited (UK)
  • Evotec AG (Germany)
  • Forest Laboratories, LLC (US)
  • GlaxoSmithKline Plc. (UK)
  • Johnson & Johnson (US)
  • Lundbeck (Denmark)
  • Novartis AG (Switzerland)
  • Parion Sciences, Inc. (US)
  • Pfizer, Inc. (US)
  • Neusentis, Inc. (US)
  • Sanofi S.A. (France)
  • Targacept, Inc. (US)
  • Xention Limited (UK)

7. GLOBAL MARKET PERSPECTIVE

    • Table 9: World Recent Past, Current and Future Analysis for Ion Channel Modulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 10: World Historic Review for Ion Channel Modulators by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 11: World 12-Year Perspective for Ion Channel Modulators by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Overview
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 12: The US Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 13: The US Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 14: Canadian Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 15: Canadian Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 16: Japanese Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 17: Japanese Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Overview
  • B. Market Analytics
    • Table 18: European Recent Past, Current and Future Analysis for Ion Channel Modulators by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 19: European Historic Review for Ion Channel Modulators by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 20: European 12-Year Perspective for Ion Channel Modulators by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2018 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Sanofi S.A. - A Key Player
  • B. Market Analytics
    • Table 21: French Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 22: French Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Key Players
  • B. Market Analytics
    • Table 23: German Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 24: German Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 25: Italian Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 26: Italian Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Strategic Corporate Development
    • Select Key Players
  • B. Market Analytics
    • Table 27: The UK Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 28: The UK Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 29: Spanish Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 30: Spanish Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 31: Russian Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 32: Russian Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Key Players
  • B. Market Analytics
    • Table 33: Rest of Europe Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 34: Rest of Europe Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • Market Analysis
    • Table 35: Asia-Pacific Recent Past, Current and Future Analysis for Ion Channel Modulators by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 36: Asia-Pacific Historic Review for Ion Channel Modulators by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 37: Asia-Pacific 12-Year Perspective for Ion Channel Modulators by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2018 (includes corresponding Graph/Chart)

5a. CHINA

  • Market Analysis
    • Table 38: Chinese Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 39: Chinese Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5b. INDIA

  • Market Analysis
    • Table 40: Indian Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 41: Indian Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5c. REST OF ASIA-PACIFIC

  • Market Analysis
    • Table 42: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 43: Rest of Asia-Pacific Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 44: Latin American Recent Past, Current and Future Analysis for Ion Channel Modulators by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 45: Latin American Historic Review for Ion Channel Modulators with Annual Sales in US$ Million by Geographic Region - Brazil and Rest of Latin America Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 46: Latin American 12-Year Perspective for Ion Channel Modulators by Geographic Region - Percentage Breakdown of Dollar Sales for Brazil and Rest of Latin America Markets for Years 2007, 2015 & 2018 (includes corresponding Graph/Chart)

6a. BRAZIL

  • Market Analysis
    • Table 47: Brazilian Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 48: Brazilian Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA

  • Market Analysis
    • Table 49: Rest of Latin America Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 50: Rest of Latin America Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • Market Analysis
    • Table 51: Rest of World Recent Past, Current and Future Analysis for Ion Channel Modulators with Annual Sales in US$ Million for Years 2014 through 2018 (includes corresponding Graph/Chart)
    • Table 52: Rest of World Historic Review for Ion Channel Modulators with Annual Sales in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top